References
Cheng J, Cuk K, Heil J, Golatta M, Schott S, Sohn C, Schneeweiss A, Burwinkel B, Surowy H (2017) Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence. Oncotarget 8(33):54537–54547
Cheng J, Tang Q, Cao X, Burwinkel B (2017) Cell-free circulating DNA Integrity based on peripheral blood as a biomarker for diagnosis of cancer: a systematic review. Cancer Epidemiol Biomark Prev. https://doi.org/10.1158/1055-9965.EPI-17-0502
Giacona MB, Ruben GC, Iczkowski KA, Roos TB, Porter DM, Sorenson GD (1998) Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas 17(1):89–97
Jiang P et al (2015) Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proc Natl Acad Sci USA 112(11):E1317–E1325
Maltoni R et al (2017) Cell-free DNA detected by “liquid biopsy” as a potential prognostic biomarker in early breast cancer. Oncotarget 8(10):16642–16649
Cheng J et al (2018) Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer. Breast Cancer Res Treat. https://doi.org/10.1007/s10549-018-4666-5
Madhavan D et al (2014) Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis. Breast Cancer Res Treat 146(1):163–174
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cheng, J., Burwinkel, B. Cell-free DNA in breast cancer: a long way to go. Breast Cancer Res Treat 170, 201–202 (2018). https://doi.org/10.1007/s10549-018-4731-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-018-4731-0